Results
1 -
10 of
16Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors, Naunyn-Schmiedeberg's Archives of Pharmacology Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests, Forensic Toxicology Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review, Forensic Toxicology Cross-reactivities of 41 new amphetamine designer drugs to EMIT?? immunoassays, Forensic Toxicology Enantiomeric separation of amphetamine, methamphetamine and ring substituted amphetamines by means of a ??-cyclodextrin-chiral stationary phase, Chromatographia Development and Validation of an LC-UV Method for Quantitation of 4-Bromo-2,5-Dimethoxyamphetamine (DOB), 4-Bromo-2,5-Dimethoxyphenetylamine (2C-B), Methylphenidate, Fenproporex and Amfepramone, Chromatographia ??-Naphthoquinone sulfonate as electrochemical labelling reagent for high-sensitivity LC analysis of drugs in biological fluids, Chromatographia Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex, Psychopharmacology Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor, Psychopharmacology Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinoginic drugs, Psychopharmacology